662.24
price up icon0.64%   4.22
after-market アフターアワーズ: 662.03 -0.21 -0.03%
loading
前日終値:
$658.02
開ける:
$657.23
24時間の取引高:
1.37M
Relative Volume:
0.67
時価総額:
$244.86B
収益:
$45.20B
当期純損益:
$6.87B
株価収益率:
36.41
EPS:
18.1888
ネットキャッシュフロー:
$6.75B
1週間 パフォーマンス:
-2.15%
1か月 パフォーマンス:
+8.60%
6か月 パフォーマンス:
+33.49%
1年 パフォーマンス:
+26.19%
1日の値動き範囲:
Value
$652.50
$662.54
1週間の範囲:
Value
$635.32
$694.33
52週間の値動き範囲:
Value
$435.27
$694.33

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Name
名前
Thermo Fisher Scientific Inc
Name
セクター
Healthcare (1051)
Name
電話
(781) 622-1000
Name
住所
168 THIRD AVENUE, WALTHAM, MA
Name
職員
125,000
Name
Twitter
@thermofisher
Name
次回の収益日
2026-10-21
Name
最新のSEC提出書
Name
TMO's Discussions on Twitter

Compare TMO vs DHR, NTRA, A, IQV

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TMO icon
TMO
Thermo Fisher Scientific Inc
662.24 244.86B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
221.20 155.50B 24.78B 3.68B 5.29B 5.1743
NTRA icon
NTRA
Natera Inc
397.77 57.34B 2.50B -226.32M 71.51M -1.6412
A icon
A
Agilent Technologies Inc
171.33 48.30B 7.23B 1.41B 1.09B 4.979
IQV icon
IQV
Iqvia Holdings Inc
262.21 43.16B 16.63B 1.39B 2.12B 8.0674

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-09-09 アップグレード UBS Neutral → Buy
2026-09-03 開始されました CLSA Outperform
2026-06-26 再開されました Bernstein Mkt Perform
2026-06-11 開始されました Piper Sandler Neutral
2026-06-03 ダウングレード HSBC Securities Buy → Hold
2026-06-02 再開されました Wolfe Research Outperform
2026-05-15 再開されました RBC Capital Mkts Sector Perform
2026-03-27 開始されました DZ Bank Buy
2025-12-11 アップグレード Citigroup Neutral → Buy
2025-12-09 開始されました Goldman Buy
2025-12-08 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2025-12-02 再開されました Morgan Stanley Overweight
2025-12-01 アップグレード HSBC Securities Hold → Buy
2025-09-11 アップグレード Barclays Equal Weight → Overweight
2025-08-19 開始されました William Blair Outperform
2025-07-24 ダウングレード HSBC Securities Buy → Hold
2025-07-11 アップグレード Scotiabank Sector Perform → Sector Outperform
2025-07-09 ダウングレード UBS Buy → Neutral
2025-01-10 アップグレード Bernstein Mkt Perform → Outperform
2024-12-23 開始されました Scotiabank Sector Perform
2024-10-14 開始されました Redburn Atlantic Buy
2024-10-01 開始されました Stephens Overweight
2024-08-28 開始されました Wells Fargo Overweight
2024-06-03 再開されました Jefferies Buy
2024-03-18 再開されました Citigroup Neutral
2024-01-24 ダウングレード Barclays Overweight → Equal Weight
2024-01-08 ダウングレード Bernstein Outperform → Mkt Perform
2023-12-18 開始されました HSBC Securities Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-10-26 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2023-10-25 アップグレード Wells Fargo Underweight → Equal Weight
2023-09-28 開始されました Bernstein Outperform
2023-09-06 再開されました Citigroup Buy
2023-07-19 開始されました Raymond James Outperform
2023-07-19 繰り返されました Robert W. Baird Outperform
2023-07-13 アップグレード Credit Suisse Neutral → Outperform
2023-04-04 繰り返されました Barclays Overweight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-07 開始されました RBC Capital Mkts Outperform
2022-10-27 ダウングレード The Benchmark Company Buy → Hold
2022-08-25 開始されました Credit Suisse Neutral
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2022-01-26 再開されました Barclays Overweight
2021-10-20 アップグレード Citigroup Neutral → Buy
2021-10-15 再開されました Cowen Outperform
2021-08-05 再開されました Credit Suisse Outperform
2021-07-16 開始されました The Benchmark Company Buy
2021-03-18 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-03 開始されました Barclays Overweight
2021-01-08 アップグレード Credit Suisse Neutral → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-02 開始されました Goldman Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-09-14 開始されました Morgan Stanley Overweight
2020-08-20 再開されました JP Morgan Overweight
2020-07-15 アップグレード Cleveland Research Neutral → Buy
2020-07-07 繰り返されました Needham Buy
2020-04-23 繰り返されました Needham Buy
2020-01-31 繰り返されました Needham Buy
2020-01-22 開始されました Credit Suisse Neutral
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Buy
2019-11-15 開始されました Stifel Buy
2019-07-25 繰り返されました Needham Buy
2019-07-16 ダウングレード Needham Strong Buy → Buy
2019-05-30 開始されました Wolfe Research Outperform
2019-05-23 繰り返されました Needham Strong Buy
2019-04-22 繰り返されました Needham Strong Buy
2019-04-16 繰り返されました BofA/Merrill Buy
すべてを表示

Thermo Fisher Scientific Inc (TMO) 最新ニュース

pulisher
09:41 AM

Thermo Fisher Scientific stock trades at EUR 587.70, volume is 4.1 percent of average - ad-hoc-news.de

09:41 AM
pulisher
09:10 AM

Morgan Stanley Adjusts Price Target on Thermo Fisher Scientific to $730 From $650 - marketscreener.com

09:10 AM
pulisher
05:09 AM

BofA raises Thermo Fisher target to USD 745 from USD 650 for Thermo Fisher Scientific stock - ad-hoc-news.de

05:09 AM
pulisher
01:34 AM

Thermo Fisher Scientific stock pre-market at EUR 587.40 - ad-hoc-news.de

01:34 AM
pulisher
Oct 09, 2026

Thermo Fisher Scientific Inc Stock 12‑Month Price Target Raised to $682.12, Implies 5% Upside - TradingView

Oct 09, 2026
pulisher
Oct 09, 2026

Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect - Barchart.com

Oct 09, 2026
pulisher
Oct 09, 2026

Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.

Oct 09, 2026
pulisher
Oct 08, 2026

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch

Oct 08, 2026
pulisher
Oct 08, 2026

What Could Thermo Fisher Scientific (TMO) Change With Its New Digital CMC Consortium? - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight - Yahoo Finance

Oct 08, 2026
pulisher
Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) stock price, news, quote and history - Yahoo Finance UK

Oct 07, 2026
pulisher
Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 07, 2026
pulisher
Oct 07, 2026

Is This the Right Time to Add TMO Stock to Your Portfolio? - Zacks Investment Research

Oct 07, 2026
pulisher
Oct 06, 2026

Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch

Oct 06, 2026
pulisher
Oct 06, 2026

JPMorgan Adds AmEx, Thermo Fisher and Liberty Energy to October Overweight Picks - BigGo Finance

Oct 06, 2026
pulisher
Oct 06, 2026

Thermo Fisher Scientific stock heads into October 21 results after a 2.27 percent drop - AD HOC NEWS

Oct 06, 2026
pulisher
Oct 06, 2026

Thermo Fisher Scientific (TMO): Strong Q3 Guidance and Broadening Demand Support Multi-Year Outlook - Yahoo Finance

Oct 06, 2026
pulisher
Oct 06, 2026

Barclays Adjusts Thermo Fisher Scientific Price Target to $750 From $650, Maintains Overweight Rating - marketscreener.com

Oct 06, 2026
pulisher
Oct 06, 2026

Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis - GlobeNewswire Inc.

Oct 06, 2026
pulisher
Oct 06, 2026

Preparations begin for Quantum BioPharma's planned Phase 2 multiple sclerosis drug trial - Stock Titan

Oct 06, 2026
pulisher
Oct 06, 2026

Exclusive: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial - Benzinga

Oct 06, 2026
pulisher
Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - BioSpace

Oct 06, 2026
pulisher
Oct 06, 2026

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

Oct 06, 2026
pulisher
Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - Business Wire

Oct 06, 2026
pulisher
Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - Zacks Investment Research

Oct 06, 2026
pulisher
Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - TradingView

Oct 06, 2026
pulisher
Oct 05, 2026

Thermo Fisher Scientific Inc (TMO) Stock Up 3.4% but GF Value Sa - GuruFocus

Oct 05, 2026
pulisher
Oct 05, 2026

Thermo Fisher Scientific Inc Stock (TMO) Closed Up by 3.35% on Oct 5: Key Drivers Unveiled - TradingKey

Oct 05, 2026
pulisher
Oct 05, 2026

Thermo Fisher Scientific accelerates market access by prioritizing the right KOLs - MedTech Dive

Oct 05, 2026
pulisher
Oct 05, 2026

Here’s How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years - Benzinga

Oct 05, 2026
pulisher
Oct 05, 2026

Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study - Business Wire

Oct 05, 2026
pulisher
Oct 05, 2026

Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus - Zacks Investment Research

Oct 05, 2026
pulisher
Oct 05, 2026

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.

Oct 05, 2026
pulisher
Oct 05, 2026

Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity - GlobeNewswire Inc.

Oct 05, 2026
pulisher
Oct 05, 2026

Cell and Gene Therapy Biomanufacturing MarketSize, Share, and Forecast, 2026-2031 | Automation, Viral Vectors, and CDMO Expansion Drive 11.7% CAGR to $8.7 Billion - GlobeNewswire Inc.

Oct 05, 2026
pulisher
Oct 05, 2026

Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.

Oct 05, 2026
pulisher
Oct 05, 2026

Global Methyl Grignard Reagent MarketStrategic Forecast, 2026-2032 | Pharmaceutical Demand, AI Process Control, and Resilient Supply Chains Unlock Growth Opportunities - GlobeNewswire Inc.

Oct 05, 2026
pulisher
Oct 04, 2026

Thermo Fisher Scientific Inc. (TMO) options chain - Yahoo Finance Australia

Oct 04, 2026
pulisher
Oct 04, 2026

Thermo Fisher Scientific Inc. (TMO) options chain - Yahoo Finance Australia

Oct 04, 2026
pulisher
Oct 01, 2026

Thermo Fisher Scientific Inc (TMO) Shares Fall 3.3% -- What GF S - GuruFocus

Oct 01, 2026
pulisher
Oct 01, 2026

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch

Oct 01, 2026
pulisher
Oct 01, 2026

Thermo Fisher Scientific Inc Stock (TMO) Closed Down by 3.34% on Oct 1: What Signal Does It Send? - tradingkey.com

Oct 01, 2026
pulisher
Oct 01, 2026

Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.

Oct 01, 2026
pulisher
Oct 01, 2026

Continuous Bioprocessing Technologies MarketGlobal Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR - GlobeNewswire Inc.

Oct 01, 2026
pulisher
Oct 01, 2026

Should CHO K1 Media Launch Require Action From Thermo Fisher Scientific Stock Investors? - Simply Wall Street

Oct 01, 2026
pulisher
Sep 30, 2026

Thermo Fisher Scientific Inc (TMO) Stock Forecasts - Yahoo Finance

Sep 30, 2026
pulisher
Sep 30, 2026

North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.

Sep 30, 2026
pulisher
Sep 29, 2026

Thermo Fisher Scientific Inc (TMO) Stock Up 0.1% but GF Value Sa - gurufocus.com

Sep 29, 2026
pulisher
Sep 29, 2026

Thermo Fisher (TMO) director's deferred stock units total 2,846.55 after a quarterly credit - Stock Titan

Sep 29, 2026
pulisher
Sep 29, 2026

At $675 per unit, a Thermo Fisher (TMO) director was credited with 62.96 stock units. - Stock Titan

Sep 29, 2026

Thermo Fisher Scientific Inc (TMO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Thermo Fisher Scientific Inc (TMO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Pettiti Gianluca
Officer
Aug 31 '26
Proposed Sale
614.38
4,133
2,539,233
0
Pettiti Gianluca
President & COO
Aug 31 '26
Sale
614.38
4,133
2,539,233
23,216
CASPER MARC N
Chairman & CEO
Aug 24 '26
Sale
627.05
275
172,439
123,925
CASPER MARC N
Chairman & CEO
Aug 24 '26
Option Exercise
309.63
275
85,148
124,200
CASPER MARC N
Officer
Aug 24 '26
Proposed Sale
627.05
275
172,438
0
CASPER MARC N
Chairman & CEO
Aug 21 '26
Sale
626.92
10,000
6,269,153
123,925
CASPER MARC N
Officer
Aug 21 '26
Proposed Sale
626.91
10,000
6,269,123
0
CASPER MARC N
Officer
Aug 20 '26
Proposed Sale
629.27
10,000
6,292,653
0
CASPER MARC N
Chairman & CEO
Aug 20 '26
Option Exercise
309.63
10,000
3,096,300
133,925
CASPER MARC N
Chairman & CEO
Aug 20 '26
Option Exercise
309.63
10,000
3,096,300
133,925
DHR DHR
$221.20
price up icon 0.63%
$397.77
price down icon 0.73%
A A
$171.33
price up icon 0.46%
IQV IQV
$262.21
price up icon 0.90%
WAT WAT
$432.10
price down icon 0.38%
$276.67
price down icon 0.54%
大文字化:     |  ボリューム (24 時間):